Millipore Sigma Vibrant Logo
Attention: We have moved. Merck Millipore products are no longer available for purchase on MerckMillipore.com.Learn More

AGX841 Recombinant SARS-CoV-2 Nucleocapsid Protein（fragment）

This e. coli recombinant SARS-CoV-2 Nucleocapsid Protein（fragment）, Cat. No. AGX841 is tested for use in ELISA.

AGX841
1 mg  
Purchase on Sigma-Aldrich

Overview

Replacement Information
Description
Catalogue NumberAGX841
DescriptionRecombinant SARS-CoV-2 Nucleocapsid Protein（fragment）
Alternate Names
  • Severe acute respiratory syndrome coronavirus 2
  • 2019-nCoV
Background InformationCoronavirus disease 2019 (COVID-19) is an infectious disease caused by the virus strain severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. A SARS-CoV-2 nucleocapsid antigen can be used to support the detection of SARS-CoV-2 (COVID-19, 2019-nCoV).
References
Product Information
FormatPurified
PresentationPurified recombinant protein in 0.01M PBS, pH7.4
Quality LevelMQ100
Applications
ApplicationThis e. coli recombinant SARS-CoV-2 Nucleocapsid Protein（fragment）, Cat. No. AGX841 is tested for use in ELISA.
Key Applications
  • ELISA
Biological Information
CloneN/A
ConcentrationPlease refer to guidance on suggested starting dilutions and/or titers per application and sample type.
HostE. coli
SpecificitySARS CoV2
Purification Methodni-sepharose
UniProt Number
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Usage Statement
  • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Storage and Shipping Information
Storage ConditionsStable for 1 year at -20°C from date of receipt. Handling Recommendations: Upon receipt and prior to removing the cap, centrifuge the vial and gently mix the solution. Aliquot into microcentrifuge tubes and store at -20°C. Avoid repeated freeze/thaw cycles.
Packaging Information
Material Size1 mg
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Catalogue Number GTIN
AGX841 04061842443543

Documentation

Recombinant SARS-CoV-2 Nucleocapsid Protein（fragment） MSDS

Title

Safety Data Sheet (SDS) 

Recombinant SARS-CoV-2 Nucleocapsid Protein（fragment） Certificates of Analysis

TitleLot Number
Recombinant SARS-CoV-2 Nucleocapsid Protein (fragment) - 3802602 3802602
Recombinant SARS-CoV-2 Nucleocapsid Protein (fragment) - 3842809 3842809
Recombinant SARS-CoV-2 Nucleocapsid Protein (fragment) - 3852787 3852787
Recombinant SARS-CoV-2 Nucleocapsid Protein（fragment) - 3671754 3671754
Recombinant SARS-CoV-2 Nucleocapsid Protein（fragment) - Q3471655 Q3471655